News

Over the past months, we have worked on creating a platform that makes it easier to explore who we are, what we do, and how we support our customers ...

ABX Acquires TRIMT GmbH to Accelerate the Next Generation of Integrin-Targeted TheranosticsAcquisition adds a proprietary cyclopeptide platform and investigational αvβ6- and αvβ8-integrin targeted…

As part of the construction work on the property at Pillnitzer Straße, we place great importance on protecting nature and biodiversity. The planning and implementation of all measures are carried out…

ABX is investing in the future: By expanding our site on Pillnitzer Street in Radeberg, we are creating new capacities and strengthening regional value creation.A key part of this project is the…

With the addition of its own dedicated transport vehicle, ABX has reached another important milestone and further strengthened its logistics capabilities.This enables us to complement our proven…

A New Chapter in High-Risk Prostate Cancer DiagnosticsThe Working Group for Urological Oncology (AUO) has selected the clinical study EAGLE-i (AP 152/25) as its Study of the Month for February 2026.…

Decontamination Project on Pillnitzer Straße: EU and Free State of Saxony Support Remediation for Planned ABX Site ExpansionMinister for the Environment and Agriculture Georg Ludwig von Breitenbuch…

On Thursday, January 8, 2026 we were pleased to welcome distinguished guests to ABX in Radeberg: Saxony’s Minister for Economic Affairs, Dirk Panter, the Mayor of Radeberg, Frank Höhme,…

We’re Looking Forward to Meeting You Around the World in 20262026 will be an exciting year for us – and we are very much looking forward to it.Throughout the year, we will be present at international…

ABX is member of the new Radiopharmacy Cluster Dresden named nukliD®Now it's final: We had the honor of signing the "Memorandum of Understanding" for the new cluster nukliD- Radiopharmacy Cluster…

Dr. Marco Müller takes over the management of ABXRadeberg, August 13, 2024. Marco Müller (PhD) took over the General Management of ABX on August 1st, 2024. He succeeds the founder and previous sole…

• Novel radiotracer for the detection of prostate cancer gets green light in Germany• Marketing authorisation now obtained in eight European countries• Radelumin® already in application in France…